Healios K.K.

Healios K.K.verified

HLOSF

Price:

$3.4

Market Cap:

$43.03B

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company is also developing cellular and tissue-based products comprising HLCR011 and HLCR012 that are iPSC regenerative medicines for the treatment of age-related macular degeneration; HLCL041, an iPSC regenerative medicine for the treatment of metabolic liver disease; and HLCM051, a regenerative medicine for treatment of ischemic stroke and acute respiratory distress syndrome, as well as HLCN061 for treating solid tumors. Healios K.K. has a joint research agreement with the Hyogo Medical University on cancer immunotherapi...[Read more]

Industry

Biotechnology

IPO Date

2020-11-09

Stock Exchange

OTC

Ticker

HLOSF

The Enterprise Value as of December 2025 (TTM) for Healios K.K. (HLOSF) is 39.39B

According to Healios K.K.’s latest financial reports and current stock price. The company's current Enterprise Value is 39.39B. This represents a change of 55.27% compared to the average of 25.37B of the last 4 quarters.

Healios K.K. (HLOSF) Historical Enterprise Value (quarterly & annually)

How has HLOSF Enterprise Value performed in the past?

The mean historical Enterprise Value of Healios K.K. over the last ten years is 52.93B. The current 39.39B Enterprise Value has changed 7.34% with respect to the historical average. Over the past ten years (40 quarters), HLOSF's Enterprise Value was at its highest in in the December 2020 quarter at 98.61B. The Enterprise Value was at its lowest in in the December 2023 quarter at 10.11B.

Quarterly (TTM)
Annual

Average

52.93B

Median

66.36B

Minimum

9.03B

Maximum

98.62B

Healios K.K. (HLOSF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Healios K.K. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 152.64%

Maximum Annual Enterprise Value = 98.62B

Minimum Annual Increase = -76.40%

Minimum Annual Enterprise Value = 9.03B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202414.65B62.24%
20239.03B-40.50%
202215.18B-76.40%
202164.31B-34.80%
202098.62B44.17%
201968.41B-6.68%
201873.30B4.66%
201770.03B-15.56%
201682.94B152.64%
201532.83B-40.20%

Healios K.K. (HLOSF) Average Enterprise Value

How has HLOSF Enterprise Value performed in the past?

The current Enterprise Value of Healios K.K. (HLOSF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

12.95B

5-year avg

40.36B

10-year avg

52.93B

Healios K.K. (HLOSF) Enterprise Value vs. Peers

How is HLOSF’s Enterprise Value compared to its peers?

Healios K.K.’s Enterprise Value is greater than Avacta Group Plc (355.89M), greater than BioInvent International AB (publ) (1.43B), greater than Northwest Biotherapeutics, Inc. (439.79M), greater than PureTech Health plc (150.89M), greater than MedinCell S.A. (859.57M), greater than CytoDyn Inc. (438.46M), greater than Immutep Limited (316.92M), greater than Clinuvel Pharmaceuticals Limited (394.46M), greater than Cresco Labs Inc. (785.93M), greater than Cellectis S.A. (381.66M),

Build a custom stock screener for Healios K.K. (HLOSF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Healios K.K. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Healios K.K. (HLOSF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Healios K.K. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Healios K.K.'s Enterprise Value?

What is the highest Enterprise Value for Healios K.K. (HLOSF)?

What is the 3-year average Enterprise Value for Healios K.K. (HLOSF)?

What is the 5-year average Enterprise Value for Healios K.K. (HLOSF)?

How does the current Enterprise Value for Healios K.K. (HLOSF) compare to its historical average?